Showing 3201-3210 of 4685 results for "".
- Remembering a Legend: Vic A Narurkar, MDhttps://practicaldermatology.com/news/remembering-a-legend-vic-a-narurkar-md/2459921/The dermatology community lost a true rock star with the sudden passing of Vic A Narurkar MD, FAAD in late January. Loved by so many, Dr. Narurkar was the Founder of the Bay Area Laser Institute in San Francisco and a past president of the American Society of Cosmetic Derma
- RealSelf Acquires Tajmeeli.com to Serve Arabic-Speaking Medical Aesthetics Markethttps://practicaldermatology.com/news/realself-acquires-tajmeelicom-to-aerve-arabic-speaking-medical-aesthetics-market/2460660/RealSelf now owns Tajmeeli, the leading cosmetic procedure resource for Arabic speaking consumers. The acquisition adds one million Arabic-speaking monthly active users. "We're excited this acquisition will enable us to expand our reach and resources to over 100 countries
- Integrated Dermatology Appoints Tushar Ramani, MD, as CEOhttps://practicaldermatology.com/news/integrated-dermatology-appoints-tushar-ramani-md-ceo/2462493/Integrated Dermatology has announced the appointment of Tushar Ramani, MD, as the company's new chief executive officer (CEO). Dr. Ramani will be replacing Jeff Queen, who after two decades as CEO and executive chairman, is transitioning to the role of co-executive chairman of the Board alongside
- DEKA Medical Receives FDA Clearance for the Synchro REPLA:Yhttps://practicaldermatology.com/news/20140213-deka_medical_receives_fda_clearance_for_the_synchro_replay/2459343/The FDA cleared DEKA Medical, Inc.'s Synchro REPLA:Y, an aesthetic workstation dedicated, but not limited, to high speed stable long-term, or permanent hair reduction, treatment of PFB, treatment of benign pigmented lesions, treatment of wrinkles and
- Elevator Pitch Sessions Launching from The Medical Entrepreneurhttps://practicaldermatology.com/news/20130924-elevator_pitch_sessions_launching__from_the_medical_entrepreneur/2459454/The Medical Entrepreneur Symposium is introducing a one day event on Saturday December 7 in Delray Beach. The “Elevator Pitch Sessions” will be geared towards helping physicians learn how to fund their next venture. "We are excite
- Medical Entrepreneur Symposium: Registration Open, Sponsors Invitedhttps://practicaldermatology.com/news/20130226-medical_entrepreneur_symposium_registration_open_sponsors_invited/2459606/The 2nd Annual The Medical Entrepreneur Symposium for physicians, office managers and physician entrepreneurs, to be held in Delray Beach, FL April 19-21, is expected to attract over 150 healthcare (and healthcare related) professionals an
- Solta Medical Launches Consumer Campaign to Empower LGBTQ Communityhttps://practicaldermatology.com/news/solta-medical-launches-consumer-campaign-to-empower-lgbtq-community/2458538/Solta Medical, a division of Valeant Pharmaceuticals North America LLC, is supporting the LGBTQ community through a focused consumer campaign that will help shed one more layer to reveal one’s true self. In addition, Solta Medical was the exclusive medical aesthetic category sponsor of the
- Solta Medical Launches Clear + Brilliant pelo for Laser Hair Removalhttps://practicaldermatology.com/news/solta-medical-launches-clear-brilliant-pelo-for-laser-hair-removal/2458875/Solta Medical, a division of Valeant Pharmaceuticals North America LLC launched its Clear + Brilliant pelo™ laser for permanent hair reduction. The US launch of this device, which joins Solta Medical's aesthetic device portfolio, follows a unique partnership with German Medical
- Level Ex Expands into Dermatology with Launch of Top Derm Medical Education Gamehttps://practicaldermatology.com/news/level-ex-expands-into-dermatology-with-launch-of-top-derm-medical-education-game/2460854/Level Ex, creator of medical video games for physicians, has expanded into the dermatology field with the launch of its newest medical mobile game, Top Derm. The company&rs
- FDA Approves First Medication to Treat Severe Frostbitehttps://practicaldermatology.com/news/fda-approves-first-medication-to-treat-severe-frostbite/2462244/The FDA has approved Eicos Sciences' Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation. “This approval provides patients with the first-ever treatment option for severe frostbite,” Norman Stockbridge, MD, PhD